321 related articles for article (PubMed ID: 1285732)
1. Disseminated candidiasis due to amphotericin B-resistant Candida albicans.
Conly J; Rennie R; Johnson J; Farah S; Hellman L
J Infect Dis; 1992 Apr; 165(4):761-4. PubMed ID: 1285732
[TBL] [Abstract][Full Text] [Related]
2. Amphotericin B-resistant Candida albicans.
Hopfer RL
J Infect Dis; 1992 Nov; 166(5):1196-8. PubMed ID: 1402037
[No Abstract] [Full Text] [Related]
3. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
Paniagua GL; Monroy E; Negrete E; Vaca S
Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
[TBL] [Abstract][Full Text] [Related]
5. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
Brenciaglia MI; Ghezzi MC; Cipriani P; Mancini C; Trancassini M
Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
Ahearn DG; McGlohn MS
J Clin Microbiol; 1984 Mar; 19(3):412-6. PubMed ID: 6325491
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
Nolte FS; Parkinson T; Falconer DJ; Dix S; Williams J; Gilmore C; Geller R; Wingard JR
Antimicrob Agents Chemother; 1997 Jan; 41(1):196-9. PubMed ID: 8980781
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of Candida albicans from patients with chronic oral candidiasis.
Holbrook WP; Kippax R
Postgrad Med J; 1979 Sep; 55(647):692-4. PubMed ID: 392486
[TBL] [Abstract][Full Text] [Related]
9. Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice.
Rabinovich S; Shaw BD; Bryant T; Donta ST
J Infect Dis; 1974 Jul; 130(1):28-31. PubMed ID: 4601179
[No Abstract] [Full Text] [Related]
10. The susceptibility of Candida albicans to amphotericin B, nystatin, and 5-fluorocytosine.
Hamra LK; Pankiewicz IJ
Med J Aust; 1977 Nov; 2(22):749-50. PubMed ID: 347230
[TBL] [Abstract][Full Text] [Related]
11. [Sensitivity of Candida spp. to 5-fluorocytosine, amphotericin B and imidazoles. Antifongiogram of 120 strains isolated at the Vaudois University Hospital Center during the autumn-winter seasons of 1978 and 1980].
Sakellarides E
Schweiz Med Wochenschr; 1981 Sep; 111(37):1367-72. PubMed ID: 7291960
[TBL] [Abstract][Full Text] [Related]
12. Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.
Radetsky M; Wheeler RC; Roe MH; Todd JK
J Clin Microbiol; 1986 Oct; 24(4):600-6. PubMed ID: 3771749
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
MartÃn E; Parras P; Lozano MC
Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
[TBL] [Abstract][Full Text] [Related]
14. Broth dilution and disc diffusion methods in the susceptibility testing of pathogenic Candida albicans against four antimycotics.
Kostiala AA; Kostiala I
Mycopathologia; 1984 Aug; 87(1-2):121-7. PubMed ID: 6092958
[TBL] [Abstract][Full Text] [Related]
15. Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis.
Hope WW; Drusano GL; Moore CB; Sharp A; Louie A; Walsh TJ; Denning DW; Warn PA
Antimicrob Agents Chemother; 2007 Jan; 51(1):285-95. PubMed ID: 17088486
[TBL] [Abstract][Full Text] [Related]
16. Intracellular killing of Candida albicans by human neutrophils is potentiated by exposure to combinations of amphotericin B and 5-fluorocytosine.
Richardson MD; Paton M; Shankland GS
Mycoses; 1991; 34(5-6):201-4. PubMed ID: 1795714
[TBL] [Abstract][Full Text] [Related]
17. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
Chen HH; Liushih RN; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
[TBL] [Abstract][Full Text] [Related]
18. Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.
Doern GV; Tubert TA; Chapin K; Rinaldi MG
J Clin Microbiol; 1986 Oct; 24(4):507-11. PubMed ID: 3533974
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of nucleic acid biosynthesis makes little difference to formation of amphotericin B-tolerant persisters in Candida albicans biofilm.
Sun J; Liu X; Jiang G; Qi Q
Antimicrob Agents Chemother; 2015 Mar; 59(3):1627-33. PubMed ID: 25547355
[TBL] [Abstract][Full Text] [Related]
20. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
Odds FC
Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
